Korsana Biosciences Statistics
NASDAQ: KRSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
32.13+0.6275 (+1.99%)
Market open · Delayed 15 min · as of Oct 8, 2:41 PM ET
Korsana Biosciences by the numbers
Korsana Biosciences has a market capitalization of $1.46 billion based on 45.54M shares outstanding. With trailing EPS of $-7.07, Korsana Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.7% above its 50-day average and 59.7% above its 200-day average.
Average daily trading volume is 29.26K shares, or about $940,124 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KRSA valuation vs. peer median
| Metric | KRSA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.46B | $1.42B | +3% |
| Avg. volume | 29.26K | 576.10K | -95% |
Peer median across 8 companies: PCRX, RAPP, NKTR, INVA, TYRA, PAHC, ANAB, GHRS.
Valuation
- Market cap
- $1.46B
- EPS (TTM)
- $-7.07
- Shares outstanding
- 45.54M
Price and trading
- Previous close
- 31.50
- Open
- 31.65
- Day range
- 31.50 – 32.69
- 52-week range
- 7.19 – 59.36
- 52-week change
- +77.31%
- Beta
- —
- Volume
- 25.22K
- Average volume
- 29.26K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 1.46B
- Forward Pe
- -9.03
- Eps
- -7.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.36
- Week52 Low
- 7.19
- Avg Volume
- 29,260.00
- Shares Outstanding
- 45.54M
- Ma50
- 29.02
- Ma200
- 20.12
- Pct From52w High
- -45.87%
- Pct From52w Low
- 346.93%